⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Xilio Therapeutics, Inc. Common Stock

$8.68
-0.32 (-3.56%)

Volume:

4.136K ($37.88K)

Market Capitalization:

$57.12M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Xilio Therapeutics Market Segments

After Hours

-0.25(-2.80%)
Open$8.93
Close$8.68
Low$8.68
Low Change-0.25 (-2.80%)
High$8.93
High Change+0.00 (+0.00%)
Range$0.25
Volume288
Dollar Volume$2.50K

Regular Trading Hours

+0.27(+2.97%)
Open$8.93
Close$9.20
Low$8.93
Low Change0.00 (0.00%)
High$9.49
High Change+0.56 (+6.27%)
Range$0.56
Volume3.848K
Dollar Volume$35.38K

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$8.93
Close$8.93
Low$8.93
Low Change0.00 (0.00%)
High$8.93
High Change+0.00 (+0.00%)
Range$0.00
Volume106
Dollar Volume$946.58

Regular Trading Hours Yesterday

+0.05(+0.56%)
Open$8.95
Close$9.00
Low$8.93
Low Change-0.02 (-0.22%)
High$9.00
High Change+0.05 (+0.56%)
Range$0.07
Volume10.788K
Dollar Volume$97.09K

Premarket Yesterday

*No Trades in Segment

Xilio Therapeutics News

There is no current news for this stock at the moment.

Xilio Therapeutics Top Trades

Xilio Therapeutics's top trade so far today returned +6.27%, while the top short trade returned -8.54%.

Xilio Therapeutics Moving Averages

5 Day Moving Average (SMA5)$8.98
10 Day Moving Average (SMA10)$9.00
20 Day Moving Average (SMA20)$9.11
50 Day Moving Average (SMA50)$9.06
100 Day Moving Average (SMA100)$8.70
200 Day Moving Average (SMA200)$5.58

Xilio Therapeutics Statistics

Average Volume (30 Days)11.78K
P/E Ratio (Current)-2.70
EPS (Current)-$3.32
Dividend Yield0.00%
Free Cash Flow-$61.27M
Cash Ratio3.98
Current Ratio4.25
Quick Ratio4.25
Debt to Equity0.00
Enterprise Value-$77.02M
EV to EBITDA2.56
EV to Sales-1.20
Price to Book0.82
Price to Cash Flow
Price to Free Cash Flow
Price to Sales0.92
Return on Assets-0.14%
Return on Equity-0.30%

Xilio Therapeutics Stock Splits

There has been 1 stock split for Xilio Therapeutics (XLO). The reverse stock split occured on March 16, 2026 and reduced the outstanding shares at a ratio of 14:1.

DateTypeRatio
Mar 16, 2026Reverse14:1

Xilio Therapeutics Dividends

There have been no dividends for Xilio Therapeutics (XLO).